P60 EVOLVING OUTCOMES OF EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA: 20-YEARS SINGLE CENTER EXPERIENCE

類似資料

• P51 | EVOLVING ATTRITION RATES IN MULTIPLE MYELOMA REAL-WORLD PRACTICE OVER A 30-YEARS PERIOD FROM A SINGLE CENTER EXPERIENCE
  著者:: G. Giunta, 等
  出版事項: (2026-04-01)
• P57 | MELFLUFEN IS EFFECTIVE AND SAFE IN MULTIPLE MYELOMA PATIENTS WITH SEVERE RENAL IMPAIRMENT
  著者:: C. Bellofiore, 等
  出版事項: (2026-04-01)
• P60 EVOLVING OUTCOMES OF EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA: 20-YEARS SINGLE CENTER EXPERIENCE
  著者:: F. Palumbo, 等
  出版事項: (2023-05-01)
• Long-Term Survival with Daratumumab, Lenalidomide and Dexamethasone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients—A Survey from Two Italian Centers
  著者:: Vittorio Del Fabro, 等
  出版事項: (2026-02-01)
• P161 | EVALUATION OF ATTRITION RATES IN REAL-LIFE SETTING: A SINGLE-CENTER SURVEY IN THE LAST 12 YEARS (2012-2024)
  著者:: O. Bianco, 等
  出版事項: (2025-09-01)